Sickle-Cell Disease Healthcare Cost in Africa: Experience of the Congo

Table 3

Severe acute sickle-cell complications and its generated factors treatment cost.

Diagnostic		%	Global management care; XAF (USD)	value
Major acute pain + bacterial infections	12	12.8	66,765 (117.50)
Hyperhemolysis + bacterial infections	18	19.2	103,492 (182.14)	= 0.041
Mixed severe acute crisis + bacterial infections	28	29.8	135,271 (238.07)
Major acute pain + malaria	4	4.2	28,305 (49.82)
Hyperhemolysis + malaria	16	17,1	64,891.63 (114.21)
Mixed severe acute crisis + malaria	8	8.5	99,944 (175.90)
Major acute pain + acute chest syndrome	2	2.1	42,800 (75.33)
Hyperhemolysis + acute chest syndrome	2	2.1	62,800 (110.52)
Mixed severe acute crisis + stroke	4	4.2	130,333 (229.38)
Total	94	100